Conditionally replicating adenoviruses as anticancer agents and ways to improve their efficacy.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of experimental therapeutics and oncology

• Publication date

  2004-04-01

• Fields of study

  Medicine

• Identifiers
  PMID 15255291
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Four Decades of Adenovirus Gene Transfer Vectors: History and Current Use.

  2025cites this paper
• Oncolytic Viruses

  2020cites this paper
• Retargeted oncolytic adenovirus displaying a single variable domain of camelid heavy-chain-only antibody in a fiber protein

  2015cites this paper
• A novel approach for detecting viable and tissue‐specific circulating tumor cells through an adenovirus‐based reporter vector

  2014cites this paper
• In Vitro Synergistic enhancement of Newcastle Disease Virus to Methotrexate cytotoxicity against tumor cells

  2013cites this paper
• A one-step ligation system for rapid generation of armed, conditionally-replicating adenoviruses

  2013cites this paper
• IL-12 initiates tumor rejection via LTi cells bearing the natural cytotoxicity receptor NKp46

  2011cites this paper
• Improving oncolytic viral therapy for glioma

  2011cites this paper
• The development of the conditionally replication‐competent adenovirus: replacement of E4 orf1‐4 region by exogenous gene

  2010cites this paper
• [Development of pegylated adenovirus vector for cancer gene therapy].

  2008cites this paper
• AdDelta24 and the p53-expressing variant AdDelta24-p53 achieve potent anti-tumor activity in glioma when combined with radiotherapy.

  2007cites this paper
• The nitroreductase prodrug SN 28343 enhances the potency of systemically administered armed oncolytic adenovirus ONYX-411NTR

  2007cites this paper
• AdΔ24 and the p53‐expressing variant AdΔ24‐p53 achieve potent anti‐tumor activity in glioma when combined with radiotherapy

  2007cites this paper
• Combination therapy of androgen-independent prostate cancer using a prostate restricted replicative adenovirus and a replication-defective adenovirus encoding human endostatin-angiostatin fusion gene

  2006cites this paper
• Intercellular spread of the transgene product to improve the efficiency of cancer gene therapy

  2006cites this paper
• Murine Model Expressing Interleukin-12 and B 7-1 in an Immunocompetent Enhanced Antitumor Effect of Oncolytic Adenovirus

  2006cites this paper
• Increased Safety with Preserved Antitumoral Efficacy on Hepatocellular Carcinoma with Dual-Regulated Oncolytic Adenovirus

  2006cites this paper
• Enhanced Antitumor Effect of Oncolytic Adenovirus Expressing Interleukin-12 and B7-1 in an Immunocompetent Murine Model

  2006cites this paper
• Viral vectors for cancer immunotherapy.

  2006cites this paper
• Vector Targeting in Gene Therapy

  2006cites this paper
• PSES - A Novel Prostate Specific Chimeric Enhancer for Prostate Cancer Gene Therapy

  2006cites this paper
• Gene-directed enzyme prodrug therapy with carboxylesterase enhances the anticancer efficacy of the conditionally replicating adenovirus AdΔ24

  2005cites this paper
• Oncolytic adenovirus expressing a p53 variant resistant to degradation by HPV E6 protein exhibits potent and selective replication in cervical cancer.

  2005cites this paper
• Conditionally replicative adenovirus expressing degradation-resistant p53 for enhanced oncolysis of human cancer cells overexpressing murine double minute 2

  2005cites this paper
• Oncolytic adenovirus that overproduces ADP and replicates selectively in tumors due to hTERT promoter-regulated E4 gene expression

  2005cites this paper
• Genetic incorporation of HSV-1 thymidine kinase into the adenovirus protein IX for functional display on the virion.

  2005cites this paper
• Gene Therapy and Virotherapy of Gastric Cancer: Preclinical Results and Clinical Developments

  2005cites this paper
• Adenoviral gene therapy combined with (selective) chemotherapy for the treatment of cancer

  2005cites this paper
• 25. Genetic Incorporation of HSV-1 Thymidine Kinase into the Adenovirus Protein IX for Functional Display on the Virion

  2005cites this paper
• Oncolytic viral therapy for human cancer: Challenges revisited

  2005cites this paper
• Oncolytic Viruses

  2004cites this paper
• Oncolytic viruses

  2002cites this paper